SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-006556
Filing Date
2024-09-20
Accepted
2024-09-20 06:02:09
Documents
15
Period of Report
2024-09-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k.htm   iXBRL 8-K 31964
2 OPINION OF POLSINELLI PC sonoma_ex0501.htm EX-5.1 9422
6 GRAPHIC image_004.jpg GRAPHIC 2736
  Complete submission text file 0001683168-24-006556.txt   224715

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE snoa-20240920.xsd EX-101.SCH 3027
4 XBRL LABEL FILE snoa-20240920_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE snoa-20240920_pre.xml EX-101.PRE 24173
17 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3667
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 241311597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)